Shibo Jiang. A5—A dual-target antiviral compound that rewrites the rules of influenza therapyJ. Acta Pharmaceutica Sinica B, 2025, 15(8): 4322-4323. DOI: 10.1016/j.apsb.2025.07.033
|
Citation:
|
Shibo Jiang. A5—A dual-target antiviral compound that rewrites the rules of influenza therapyJ. Acta Pharmaceutica Sinica B, 2025, 15(8): 4322-4323. DOI: 10.1016/j.apsb.2025.07.033
|
Shibo Jiang. A5—A dual-target antiviral compound that rewrites the rules of influenza therapyJ. Acta Pharmaceutica Sinica B, 2025, 15(8): 4322-4323. DOI: 10.1016/j.apsb.2025.07.033
|
Citation:
|
Shibo Jiang. A5—A dual-target antiviral compound that rewrites the rules of influenza therapyJ. Acta Pharmaceutica Sinica B, 2025, 15(8): 4322-4323. DOI: 10.1016/j.apsb.2025.07.033
|
DownLoad: